A Phase 1b, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate Safety, Engraftment, and Initial Signs of Clinical Activity of MB310 in Patients with Active, Mild to Moderate Ulcerative Colitis (COMPOSER-1)

2023-507376-50-00 Protocol MB310-01 Human pharmacology (Phase I) - First administration to humans Ended

Start 27 Sep 2024 · End 9 Jan 2026 · Status Ended · 4 EU/EEA countries · 20 sites · Protocol MB310-01

Overview

Sponsor-declared trial summary

Phase Human pharmacology (Phase I) - First administration to humans
Status Ended
Participants planned 55
Countries 4
Sites 20

Ulcerative Colitis

Key facts

Sponsor
Microbiotica Limited
Participant type
Patients
Age range
18-64 years, 65+ years
Gender
Male and Female
Therapeutic area
Diseases [C] - Digestive System Diseases [C06]
Trial duration
27 Sep 2024 → 9 Jan 2026
Decision date (initial)
2024-08-19
Transition trial
No
Low-intervention
No
Rare-disease indication
No
Vulnerable population
Yes

External identifiers

EU CT number
2023-507376-50-00
WHO UTN
U1111-1304-8241

Trial design

CTIS Part I — objectives, methods, condition coding

Conditions and MedDRA coding

Ulcerative Colitis

VersionLevelCodeTermSystem organ class
20.0 PT 10009900 Colitis ulcerative 100000004856

Sponsors and contacts

Sponsor organisations, regulatory contacts, third parties

Microbiotica Limited

Sponsor organisation
Microbiotica Limited
Address
The Newham Building, Chesterford Park, Little Chesterford Chesterford Park Little Chesterford
City
Saffron Walden
Postcode
CB10 1XL
Country
United Kingdom

Scientific contact point

Organisation
Microbiotica Limited
Contact name
Microbiotica Information

Public contact point

Organisation
Microbiotica Limited
Contact name
Microbiotica Information

Locations

4 EU/EEA countries · 20 investigational sites

By country

CountryMS statusPlanned subjectsSites
Austria Ended 15 4
Bulgaria Ended 12 5
Poland Ended 14 6
Spain Ended 5 5
Rest of world
United Kingdom
9

Investigational sites

Austria

4 sites · Ended
Medical University Of Vienna
Gastroenterology and Hepatology, Waehringer Guertel 18-20, Alsergrund, Vienna
Landeskrankenanstalten-Betriebsgesellschaft Kabeg
Gastroenterology, Hepatology, Endocrinology, Rheumatology and Nephrology, Feschnigstrasse 11, Klagenfurt,09.Bez.:Annabichl, Klagenfurt Am Woerthersee
Medizinische Universitaet Innsbruck
Gastroenterology and Hepatology, Anichstrasse 35, 6020, Innsbruck
Gemeinnutzige Salzburger Landes kliniken Betriebsgesellschaft mbH
Gastroenterology and Hepatology, Muellner Hauptstrasse 48, 5020, Salzburg

Bulgaria

5 sites · Ended
Acibadem City Clinic Tokuda University Hospital EAD
Clinic of Gastroenterology, Bulevard Nikola Yonkov Vaptsarov 51b, 1407, Sofiya
Diagnostics And Consultation Center Convex Ltd.
Not Applicable, Ulitsa Sinanishko Ezero 11a, 1680, Sofiya
Umbal - Prof. D-R Stoyan Kirkovich AD
Department of Gastroenterology, Ulitsa General Stoletov 2, 6003, Stara Zagora
Diagnostics-Consultancy Center Mladost M Varna OOD
Cabinet No. 604 - Gastroenterology, Bulevard Republika 15, 9020, Varna
Medical Center Rusemed EOOD
Cabinet 505, Floor 5, Bulevard Lipnik 123, Ruse

Poland

6 sites · Ended
Medical Network Sp. z o.o.
WIP Warsaw IBD Point Profesor Kierkuś, Ul. Plowiecka 103, 04-501, Warsaw
Panstwowy Instytut Medyczny Ministerstwa Spraw Wewnetrznych I Administracji
Klinika Chorób Wewnętrznych i Gastroenterologii, Ul. Woloska 137, 02-507, Warsaw
Niepubliczny Zaklad Opieki Zdrowotnej Twoje Zdrowie El Sp. z o.o.
Poradnia gastroenterologiczna, Ul. Robotnicza 79, 82-300, Elblag
Korczowski Bartosz, Gabinet Lekarski
nd, ul. Litewska 4A/7, 35-302, Rzeszów
Centrum Medyczne Kermed Renata Bijata-Bronisz I Ewa Kowalinska Sp. j.
nd, Ul. Krolowej Jadwigi 16, 85-231, Bydgoszcz
Wojskowy Instytut Medyczny Panstwowy Instytut Badawczy
Klinika Gastroenterologii i Chorób Wewnętrznych, Ulica Szaserow 128, 04-141, Warsaw

Spain

5 sites · Ended
Hospital Universitario Juan Ramon Jimenez
Digestive, Ronda Exterior Norte S/n, 21005, Huelva
Complexo Hospitalario Universitario De Vigo
Gastroenterology, Estrada Clara Campoamor N 341, 36312, Vigo
Centro Medico Teknon-Grupo Quironsalud
Gastroenterology, Calle Vilana 12, 08022, Barcelona
Parc Tauli Hospital Universitari
Digestive Diseases, Parc Del Tauli 1, 08208, Sabadell
Complexo Hospitalario Universitario De Santiago
Gastroenterology, Calle Choupana Da S/n, 15706, Santiago De Compostela

Country notifications

Trial-start, recruitment-start, end and early-termination notifications submitted per Member State

Country Trial startTrial end Recruitment startRecruitment end Early termination
Austria 2024-10-01 2026-01-07 2025-03-11 2025-07-17
Bulgaria 2024-09-27 2026-01-07 2025-02-10 2025-07-17
Poland 2024-10-04 2026-01-07 2024-10-15 2025-07-17
Spain 2024-12-10 2026-01-08 2025-02-10 2025-07-17

Application history

5 submissions — initial application plus substantial / non-substantial modifications

#TypeCodeSubmittedReference MSConclusionDecision date
1 INITIAL IN 2024-04-19 Austria Acceptable
2024-08-12
2024-08-13
2 SUBSEQUENT ADDITION OF MSC APP-2 2024-09-05 Acceptable
2024-08-12
2024-11-27
3 NON SUBSTANTIAL MODIFICATION NSM-1 2024-09-05 Austria Acceptable
2024-08-12
2024-09-05
4 SUBSTANTIAL MODIFICATION SM-1 2024-09-05 Acceptable 2024-10-14
5 SUBSTANTIAL MODIFICATION SM-2 2025-06-26 Austria Acceptable
2025-08-07
2025-08-08